This inventor holds 1 USPTO granted patent. Top assignee: Yangzhou University. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Fanzeng Meng: Innovator in Monoclonal Antibody Research
Introduction
Fanzeng Meng is a prominent inventor based in Yangzhou, China. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His innovative work has led to the creation of a patented hybridoma cell line that has important applications in medical research.
Latest Patents
Fanzeng Meng holds a patent for a hybridoma cell line secreting an ActA monoclonal antibody and its use. This patent represents a crucial advancement in the production of monoclonal antibodies, which are essential tools in diagnostics and therapeutics.
Career Highlights
Fanzeng Meng is affiliated with Yangzhou University, where he conducts research and contributes to the academic community. His work at the university has allowed him to explore various aspects of biotechnology and to mentor aspiring scientists in the field.
Collaborations
Throughout his career, Fanzeng Meng has collaborated with notable colleagues, including Dan Gu and Jinlin Huang. These collaborations have fostered a productive research environment and have led to further advancements in their shared field of study.
Conclusion
Fanzeng Meng's contributions to monoclonal antibody research exemplify the impact of innovative thinking in biotechnology. His work continues to influence the development of new medical therapies and diagnostic tools.